Literature DB >> 24784415

The PI3K pathway acting on alternative HIV-1 pre-mRNA splicing.

Frank Hillebrand1,2, Steffen Erkelenz1, Nora Diehl1, Marek Widera1, Juliane Noffke3, Elita Avota4, Sibylle Schneider-Schaulies4, Marie-Christine Dabauvalle2, Heiner Schaal1.   

Abstract

HIV-1 mediates pro-survival signals and prevents apoptosis via the phosphatidylinositol-3-kinase (PI3K) pathway. This pathway, however, also affects phosphorylation of serine-arginine (SR) proteins, a family of splicing regulatory factors balancing splice site selection. We now show that pharmacologic inhibition of PI3K signalling alters the HIV-1 splicing pattern of both minigene- and provirus-derived mRNAs. This indicates that HIV-1 might also promote PI3K signalling to balance processing of its transcripts by regulating phosphorylation of splicing regulatory proteins.
© 2014 The Authors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24784415     DOI: 10.1099/vir.0.064618-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  2 in total

Review 1.  Live and let die: signaling AKTivation and UPRegulation dynamics in SARS-CoVs infection and cancer.

Authors:  Mariana Suaya; Gonzalo Manuel Sánchez; Antonella Vila; Analía Amante; Mercedes García Carrillo; María Cotarelo; Matías Blaustein
Journal:  Cell Death Dis       Date:  2022-10-03       Impact factor: 9.685

2.  An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing.

Authors:  Raymond W Wong; Ahalya Balachandran; Peter K Cheung; Ran Cheng; Qun Pan; Peter Stoilov; P Richard Harrigan; Benjamin J Blencowe; Donald R Branch; Alan Cochrane
Journal:  PLoS Pathog       Date:  2020-02-18       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.